Dianthus Therapeutics Banner

SEC Filing Details

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results

Document Details

Form
Filing Date
Feb 14, 2020
Document Date
Dec 31, 2019
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/
Filer
BONNEY MICHAEL W